It is a broadly described annual report of Sun Pharmaceutical Industries Limited in the year of 2009-2010. During the financial year, The Company’s Total Income Rs. 26467 million. Net Profit after Tax for the year Rs. 8987 million. The company’s recorded sales for 2009-10 of Rs. 39,040 million, a decline of 9% over the previous year. Equity shares final Rs. 2848. Book value per equity share (Rs. 5 paid up) Rs. 276/-.
The Board of Directors is pleased to recommend an equity dividend of Rs. 13.75 per equity share of face value Rs. 5/- each (previous year Rs. 13.75 per equity share of face value Rs. 5/- each) for the year ended 31st March 2010.
More Annual Report of Sun Pharmaceutical Industries Limited:
- Annual Report 1999-2000 of Sun Pharmaceutical Industries Limited
- Annual Report 2000-2001 of Sun Pharmaceutical Industries Limited
- Annual Report 2001-2002 of Sun Pharmaceutical Industries Limited
- Annual Report 2002-2003 of Sun Pharmaceutical Industries Limited
- Annual Report 2003-2004 of Sun Pharmaceutical Industries Limited
- Annual Report 2004-2005 of Sun Pharmaceutical Industries Limited
- Annual Report 2005-2006 of Sun Pharmaceutical Industries Limited
- Annual Report 2006-2007 of Sun Pharmaceutical Industries Limited
- Annual Report 2007-2008 of Sun Pharmaceutical Industries Limited
- Annual Report 2008-2009 of Sun Pharmaceutical Industries Limited
- Annual Report 2009-2010 of Sun Pharmaceutical Industries Limited
- Annual Report 2010-2011 of Sun Pharmaceutical Industries Limited
- Annual Report 2011-2012 of Sun Pharmaceutical Industries Limited
- Annual Report 2012-2013 of Sun Pharmaceutical Industries Limited
- Annual Report 2013-2014 of Sun Pharmaceutical Industries Limited
- Annual Report 2014-2015 of Sun Pharmaceutical Industries Limited
- Annual Report 2015-2016 of Sun Pharmaceutical Industries Limited
- Annual Report 2016-2017 of Sun Pharmaceutical Industries Limited
